Biocept Inc.

Biocept Inc.
Stock Exchange NASDAQ Stock Market
EPS
$7.16
Market Cap
$39.1 M
Shares Outstanding
18.87 M
Public Float
11.58 M

Profile

Address
5810 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.biocept.com
Updated 07/08/2019
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests.

Financials

View All
Created with Highcharts 5.0.14Biocept Inc.Net Income. Fiscal year is January-December. All values USD Thousands.9 2339 23315 86615 86616 94916 94918 39918 39921 61321 61324 57124 57120132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Biocept Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1341341331336096093 2233 2235 0685 0683 2503 25020132014201520162017201801k2k3k4k5k6k

David F. Hale
Non-Executive Chairman
Michael W. Nall
President, Chief Executive Officer & Director